/CRYO

CRYO Stock - American CryoStem Corporation

Q: What is the analyst price target for CRYO?

Analyst price target information is not currently available for CRYO.

Q: What is CRYO's market cap?

Market capitalization information is not currently available for CRYO.

Healthcare|Biotechnology|OTC

$0.00-99.75%

$0.04 (-99.75%) • Mar 5

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

SELL

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CRYO

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2017

FY2018

FY2019

FY2020

FY2021

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta11.42

52W High$0.17

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	$20,590	$557,903	$321,647	$1.10M	$1.87M
Gross Profit	$7,017	$514,066	$289,771	$806,425	$1.31M
Gross Margin	34.1%	92.1%	90.1%	73.1%	70.3%
Operating Income	$-2,205,305	$-589,077	$-951,035	$-1,272,521	$-1,020,082
Net Income	$-2,879,586	$-1,179,285	$-1,082,217	$-1,490,512	$-1,222,007
Net Margin	-13985.4%	-211.4%	-336.5%	-135.1%	-65.5%
EPS	$-0.05	$-0.02	$-0.02	$-0.03	$-0.03

Company Overview

American CryoStem Corporation develops, markets, and licenses adipose tissue derived technologies for use in the fields of Regenerative and Personalized Medicine. The company's products include CELLECT collection, transportation, and storage system, which is a solution for physicians to collect and deliver tissue samples; ATGRAFT adipose tissue storage service, a fat collection, processing, and storage solution that enables physicians to provide their patients with tissue products and cell storage options; and ATCELL adipose derived stem cells. It also offers ACSelerat cell culture media products for growing human stromal cells. In addition, the company, provides contract manufacturing services for Autokine-CM, an anti-aging topical formulation; and autologous skin care product line. American CryoStem Corporation was founded in 1987 and is based in Eatontown, New Jersey.

Visit Website

Frequently Asked Questions about CRYO

What is CRYO's current stock price?

American CryoStem Corporation (CRYO) is currently trading at $0.00 per share. The stock has moved -99.75% today.

What is the analyst price target for CRYO?

No analyst price targets are currently available for this stock.

What sector is American CryoStem Corporation in?

American CryoStem Corporation operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.

What is CRYO's market cap?

American CryoStem Corporation has a market capitalization of $0.00 billion, making it a small-cap company.

Does CRYO pay dividends?

No, American CryoStem Corporation does not currently pay a dividend to shareholders.